Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as C$0.77 and last traded at C$0.77, with a volume of 43000 shares traded. The stock had previously closed at C$0.76.
Crescita Therapeutics Price Performance
The stock has a market capitalization of C$14.15 million, a P/E ratio of 37.50 and a beta of -1.34. The stock’s fifty day moving average is C$0.72 and its 200-day moving average is C$0.56. The company has a debt-to-equity ratio of 17.34, a current ratio of 2.80 and a quick ratio of 2.29.
Crescita Therapeutics (TSE:CTX – Get Free Report) last issued its quarterly earnings data on Monday, May 11th. The company reported C($0.06) earnings per share (EPS) for the quarter. The business had revenue of C$5.64 million during the quarter. Crescita Therapeutics had a negative return on equity of 2.07% and a negative net margin of 1.38%.
Crescita Therapeutics Company Profile
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
Further Reading
- Five stocks we like better than Crescita Therapeutics
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
